Biodistribution studies for cell therapy products: Current status and issues-Reference-Cited by-同舟云学术

Biodistribution studies for cell therapy products: Current status and issues

Published:2021-12 Issue: Volume:18 Page:202-216
ISSN:2352-3204
Container-title:Regenerative Therapy
language:en
Short-container-title:Regenerative Therapy

Author:

Kamiyama Yoshiteru,Naritomi Yoichi,Moriya Yuu,Yamamoto Syunsuke,Kitahashi Tsukasa,Maekawa Toshihiko,Yahata Masahiro,Hanada Takeshi,Uchiyama Asako,Noumaru Akari,Koga Yoshiyuki,Higuchi Tomoaki,Ito Masahiko,Komatsu Hiroyuki,Miyoshi Sosuke,Kimura Sadaaki,Umeda Nobuhiro,Fujita Eriko^ORCID,Tanaka Naoko,Sugita Taku,Takayama Satoru,Kurogi Akihiko,Yasuda Satoshi^ORCID,Sato Yoji

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Developmental Biology,Biomedical Engineering,Biomaterials

Reference144 articles.

1. Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms;Basu;Toxicol Pathol,2015

2. Concise review: quantitative detection and modeling the in vivo kinetics of therapeutic mesenchymal stem/stromal cells;Brooks;Stem Cells Transl Med,2018

3. Lost signature: progress and failures in in vivo tracking of implanted stem cells;von der Haar;Appl Microbiol Biotechnol,2015

4. Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity;Gu;Theranostics,2012

5. Guidelines on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Umbilical cord mesenchymal stromal cells in serum-free defined medium display an improved safety profile;Stem Cell Research & Therapy;2023-12-12

2. Stem cells from human exfoliated deciduous teeth rejuvenate the liver in naturally aged mice by improving ribosomal and mitochondrial proteins;Cytotherapy;2023-12

3. Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells;Stem Cell Reports;2023-08

4. Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues;Cells;2023-07-05

5. Non-clinical Study of Biodistribution of Human Immature Dental Pulp Stem Cells (Nestacell® Product) Following Intravenous Administration in Mice;2023-02-07